Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size to Reach USD 5,995.46 Million Globally with Growing CAGR of 33.3% by 2029
Micro invasive glaucoma surgery (MIGS) Market is used to treat open-angle glaucoma. Initially, to treat OAG, medication was given that reduced aqueous humor production or increased aqueous humor outflow. For mild to moderate OAG, traditionally, pharmacologic and laser treatment was performed. With the coming of micro invasive glaucoma surgery (MIGS) procedures, new options were created for those not fit for conventional surgery.
An increase in the population of geriatrics and increasing government initiatives for the prevention of blindness are expected to boost the market. Rapid transition from glaucoma medication to minimally invasive glaucoma surgeries might be creating opportunities for the manufacturer of MIGS devices. However, poor reimbursement facilities might act as an obstacle for the market.
Data Bridge Market Research analyses that the micro invasive glaucoma surgery (MIGS) devices market is expected to reach the value of USD 5,995.46 million by 2029, at a CAGR of 33.3% during the forecast period. “MIGS Stents” accounts for the largest technology segment in the micro invasive glaucoma surgery (MIGS) devices market due to rapid developments in technological pathways to commercialize the use of micro invasive glaucoma surgery (MIGS) devices. The micro invasive glaucoma surgery (MIGS) devices market report also covers technological advancements in depth.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-micro-invasive-glaucoma-surgery-migs-devices-market
MIGS stands for micro invasive glaucoma surgery, which helps treat glaucoma. It is a breakthrough technology in the treatment of mild to moderate glaucoma. It is an alternative to the medications given earlier and it also prevents the complications of conventional surgery. These procedures are used to lower the intra-ocular pressure of the eye to avoid damage to the optic nerve. These procedures are safer and have a very rapid recovery time compared to conventional surgery. The various MIGS devices implanted are shunts and stents to lower the IOP.
Recent Developments
- In January 2022, Glaukos announced GLK=301’s first patient enrolment in the Phase II clinical trial for dry eye disease. After the successful approval from the regulatory body, this drug will help the company grow its business segment.
- In January 2022, Alcon acquired Ivantis, developer of the novel Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device. This surgical device is designed to lower eye pressure for open-angle glaucoma patients. This acquisition will enhance the company’s portfolio in eye surgery segment.
Key Market Competitors Covered in the Report
- Glaukos Corporation
- Ivantis Inc.
- Allergan
- Ellex
- Alcon
- BVI
- Johnson and Johnson Surgical Vision Inc. and Johnson and Johnson Vision Care Inc.(A subsidiary of Johnson and Johnson Inc.)
- Microsurgical technology
- Molteno Ophthalmic Ltd.
- New world Medical
- Santen Pharmaceutical
- Sight Scientific
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-micro-invasive-glaucoma-surgery-migs-devices-market
Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scope
Product
- MIGS stents
- MIGS shunts
- Others
On the basis of product, the micro invasive glaucoma surgery (MIGS) devices market is segmented into MIGS shunts, MIGS stents and others.
Target
- Trabecular meshwork
- Suprachoroidal space
- Subconjunctival filtration
- Reducing aqueous production
On the basis of target, the micro invasive glaucoma surgery (MIGS) devices market is segmented into the trabecular meshwork, suprachoroidal space, subconjunctival filtration and reducing aqueous production.
Surgery Type
- Glaucoma in conjunction with cataract
- Stand-alone glaucoma
On the basis of surgery, the micro invasive glaucoma surgery (MIGS) devices market is segmented into glaucoma in conjunction with cataract and stand-alone glaucoma.
End User
- Hospital outpatient departments (HOPD)
- Ophthalmology clinics
- Ambulatory surgery centers (ASCS)
- Others
On the basis of end-user, the micro invasive glaucoma surgery (MIGS) devices market is segmented into hospital outpatient departments (HOPD), ophthalmology clinics, ambulatory surgery centers (ASCS) and others.
Distribution Channel
- Direct tender
- Retail sales
Table of Contents:
Table of Contents:
1. Introduction
2. Market Segmentation
3. Executive Summary
4. Premium Insights
5. Micro Invasive Glaucoma Surgery (MIGS) Devices Market: Regulations
6. Market Overview
7. Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
8. Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Target
9. Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Application
10. Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Type
11. Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By End User
12. Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Region
13. Micro Invasive Glaucoma Surgery (MIGS) Devices Market: Company Landscape
14. SWOT Analyses
15. Company Profile
16. Questionnaires
17. Related Reports
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-micro-invasive-glaucoma-surgery-migs-devices-market
Top DBMR Healthcare Reports:
USA Micro Invasive Glaucoma Surgery (MIGS) Devices Market – Industry Trends and Forecast to 2030
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market – Industry Trends and Forecast to 2029Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product (MIGS Stents, MIGS Shunts and Others), Target (Trabecular Meshwork Suprachoroidal Space Subconjunctival Filtration and Reducing Aqueous Production), Surgery Type (Glaucoma in Conjunction with Cataract and Stand-Alone Glaucoma), End User (Hospital Outpatient Departments (HOPD), Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS) and Others), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/middle-east-and-africa-micro-invasive-glaucoma-surgery-migs-devices-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
